References
Clegg DO et al. (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39: 2004–2012
Maksymowych WP et al. (2002) Ankylosing spondylitis and current disease-controlling agents: do they work? Best Pract Res Clin Rheumatol 16: 619–630
Baraliakos X et al. (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52: 1216–1223
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ward, M. Nonsteroidal anti-inflammatory drugs: disease modifiers in ankylosing spondylitis?. Nat Rev Rheumatol 1, 18–19 (2005). https://doi.org/10.1038/ncprheum0040
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0040
- Springer Nature Limited